Aurinia Pharmaceuticals Inc (AUPH)

[W&T Capital LLC]

I didn't miss anything. Your point is further dilution is needed to bring drug to market. The board's view is no further dilution is needed because of recent comments by our CEO Dr. Glickman. Now to sway the boards view on this topic you post an article where H.C. Wainwright downgrades there price target due to further dilution. Except you failed to mention that in that specific article H.C. says this downgrade in price target is without taking into the consideration that Europe and Japan could be huge future revenue streams. With those revenue streams dilution would not be needed. Now Glickman who is privy to more information than anyone including H.C. and yourself stated that no further dilution would be needed. Why? Hello? Cause he knows he is sitting on a golden egg.